Tenaya Therapeutics Insiders Up US$152k On US$600k Investment

Insiders who purchased Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares in the past 12 months are unlikely to be deeply impacted by the stock's 13% decline over the past week. After accounting for the recent loss, the US$600k worth of shares they purchased is now worth US$752k, suggesting a good return on their investment.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

Check out our latest analysis for Tenaya Therapeutics

The Last 12 Months Of Insider Transactions At Tenaya Therapeutics

In the last twelve months, the biggest single purchase by an insider was when Scientific Founder Deepak Srivastava bought US$600k worth of shares at a price of US$2.60 per share. We do like to see buying, but this purchase was made at well below the current price of US$3.26. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insiders At Tenaya Therapeutics Have Sold Stock Recently

The last quarter saw substantial insider selling of Tenaya Therapeutics shares. In total, insiders dumped US$75k worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

Does Tenaya Therapeutics Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. It appears that Tenaya Therapeutics insiders own 5.4% of the company, worth about US$12m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

So What Does This Data Suggest About Tenaya Therapeutics Insiders?

Insiders sold Tenaya Therapeutics shares recently, but they didn't buy any. On the other hand, the insider transactions over the last year are encouraging. And insiders do own shares. So we're happy enough to look past some selling. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Case in point: We've spotted 4 warning signs for Tenaya Therapeutics you should be aware of, and 2 of them are significant.

Of course Tenaya Therapeutics may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.